The long-term goal of this research is to extend our understanding of the biological basis of evolutionary relationships between Duffy (Fy) blood group polymorphism and malaria. The specific hypothesis to be tested is that the molecular polymorphism responsible for Duffy-negativity (Fy[a-b-1) has emerged in Papua New Guinea (PNG) because it confers resistance to Plasmodium vivax blood-stage malaria. Our studies have discovered the Y GATA- I promoter mutation, which eliminates erythroid Fyb expression in Africans, on the FY* A allele in Melanesians residing in a P. vivax endemic region of PNG. This allele, therefore, appears to be independent of African origin. Flow cytometric analysis correlates this mutation with reduced erythroid Fy expression (FY*Anull). This finding in PNG provokes unresolved questions regarding the evolutionary relationship between Fy(a-b-) and malaria, such as how a """"""""non-lethal"""""""" malaria injection may contribute to selection of a mutation that has reached fixation in many African populations, and how susceptibility to P. vivax influences infection and morbidity from other malaria species, including P. falciparum. Unlike African Fy(a-b-), discovered in the absence of the parasite, FY*Anull emerges in a setting which permits future evolutionary study.
The specific aims are to: 1. Assess the distribution patterns of FY*Anull in communities within and surrounding the Wosera and their relationship to the intensity of malaria transmission and epidemiology of P. vivax, P. falciparum, P. malariae, and P. ovale infection. 2. Examine population genetic evidence implicating selection of the FY*A/FY*Anull genotype through family-based studies. 3. Examine susceptibility to P. vivax infection and morbidity comparing individuals with FY*A/ FY*Anull and FY*A/FY*A genotypes.
This aim will include prospective matched cohort studies to determine whether the FY*A/FY*Anull genotype is associated with reduced susceptibility to P. vivax infection, morbidity or changes in infection with other malaria species relative to FY*A/FY*A.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI046919-01A2
Application #
6313749
Study Section
Special Emphasis Panel (ZRG1-TMP (04))
Program Officer
Higgs, Elizabeth S
Project Start
2001-04-01
Project End
2006-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
1
Fiscal Year
2001
Total Cost
$473,344
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Zimmerman, Peter A; Ferreira, Marcelo U; Howes, Rosalind E et al. (2013) Red blood cell polymorphism and susceptibility to Plasmodium vivax. Adv Parasitol 81:27-76
Mueller, Ivo; Schoepflin, Sonja; Smith, Thomas A et al. (2012) Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. Proc Natl Acad Sci U S A 109:10030-5
Ross, Amanda; Koepfli, Cristian; Li, Xiaohong et al. (2012) Estimating the numbers of malaria infections in blood samples using high-resolution genotyping data. PLoS One 7:e42496
Koepfli, Cristian; Ross, Amanda; Kiniboro, Benson et al. (2011) Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea. PLoS Negl Trop Dis 5:e1424
Lin, Enmoore; Kiniboro, Benson; Gray, Laurie et al. (2010) Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS One 5:e9047
Ménard, Didier; Barnadas, Céline; Bouchier, Christiane et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 107:5967-71
Sam-Agudu, Nadia A; Greene, Jennifer A; Opoka, Robert O et al. (2010) TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg 82:548-55
Muller, Ivo; Genton, Blaise; Rare, Lawrence et al. (2009) Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection. Malar J 8:158
Mueller, Ivo; Widmer, Simone; Michel, Daniela et al. (2009) High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea. Malar J 8:41
King, Christopher L; Michon, Pascal; Shakri, Ahmad Rushdi et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 105:8363-8

Showing the most recent 10 out of 26 publications